HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nonsyndromic Deafness

Hearing loss that is not associated with other signs and symptoms. Most cases are due to damage to structures of the INNER EAR. More than half of congenital cases are due to genetic factors; mutations in multiple genes have been identified, including POU3F4 (OMIM: 304400), MTRNR1 (OMIM: 561000), and MT-TS1 (OMIM: 590080).
Also Known As:
Isolated Deafness; Nonsyndromic Hearing Impairment; Nonsyndromic Hearing Loss; Undifferentiated Deafness
Networked: 336 relevant articles (1 outcomes, 37 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Cystic Fibrosis (Mucoviscidosis)
2. alpha-Thalassemia
3. Familial Mediterranean Fever (Periodic Disease)
4. Glucosephosphate Dehydrogenase Deficiency
5. Deafness (Deaf Mutism)

Experts

1. Guan, Min-Xin: 25 articles (01/2017 - 01/2004)
2. Smith, Richard J H: 16 articles (05/2020 - 05/2002)
3. Friedman, Thomas B: 13 articles (04/2022 - 06/2004)
4. Dai, Pu: 12 articles (01/2018 - 10/2006)
5. Han, Dongyi: 12 articles (03/2016 - 01/2004)
6. Zheng, Jing: 11 articles (01/2017 - 01/2010)
7. Zhu, Yi: 11 articles (01/2017 - 10/2007)
8. Ahmed, Zubair M: 10 articles (04/2016 - 04/2005)
9. Riazuddin, Saima: 10 articles (04/2016 - 12/2006)
10. Belyantseva, Inna A: 9 articles (04/2022 - 04/2005)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Nonsyndromic Deafness:
1. Hemoglobins (Hemoglobin)IBA
2. Mitochondrial DNA (mtDNA)IBA
3. Connexin 26IBA
4. 12S ribosomal RNAIBA
5. AminoglycosidesIBA
6. ConnexinsIBA
7. Proteins (Proteins, Gene)FDA Link
8. DNA (Deoxyribonucleic Acid)IBA
9. human GJB3 proteinIBA
10. Ser Transfer RNAIBA

Therapies and Procedures

1. Cochlear Implants (Cochlear Implant)
2. Ligation
3. Cochlear Implantation
4. Therapeutics
5. Otoscopes